Geriatric Nutritional Risk Index Predicts Prognosis in Older Patients With Colorectal Cancer: A Multicenter Study.
By: Kazuki Otani, Keisuke Kazama, Toru Aoyama, Itaru Hashimoto, Aya Kato, Yukio Maezawa, Masakatsu Numata, Ayako Tamagawa, Yosuke Atsumi, Sho Sawazaki, Norio Yukawa, Aya Saito

Department of Surgery, Yokohama City University, Yokohama, Japan otani.kaz.tt@yokohama-cu.ac.jp.
2025-6-12; doi: 10.21873/anticanres.17759
Abstract

Background/aim

Colorectal cancer (CRC) is a major global health concern, with older patients often experiencing malnutrition, which affects treatment outcomes. The Geriatric Nutritional Risk Index (GNRI) is a simple tool for assessing the nutritional status in older adults. This study evaluated the association between the preoperative GNRI and long-term prognosis in elderly patients with CRC.

Patients

This multicenter retrospective cohort study analyzed 1,176 patients ≥65 years old who underwent curative resection for stage 0-III colorectal adenocarcinoma between 2001 and 2020. Patients were categorized into high-GNRI (hG; GNRI ≥98, n=770) and low-GNRI (lG; GNRI <98, n=406) groups. The overall survival (OS) and recurrence-free survival (RFS) were compared between groups using a Kaplan-Meier analysis and Cox proportional hazards models.

Results

The lG group had significantly more females, right-sided colon cancers, and advanced T-stage tumors and significantly more frequent postoperative complications than the hG group. A multivariate analysis identified GNRI as an independent prognostic factor for both the OS and RFS. Respective 3-year OS rates were 91.4% and 80.6%, and respective 3-year RFS rates were 84.8% and 73.8% in the hG and lG groups. Hematogenous recurrence was significantly more common in the lG group than in the hG group (16.7% vs. 10.5%, p=0.003).

Conclusion

The preoperative GNRI was an independent prognostic factor for long-term outcomes in older patients with CRC. This easily calculated index provides valuable complementary information to traditional staging systems and can be readily implemented in clinical practice to identify high-risk patients who may benefit from intensive perioperative management.



Copyright © 2025 International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

PMID:40876990






Copyright 2026 InterMDnet | Privacy Policy | Disclaimer | System Requirements